Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 1065-1075

  Byrum, Robert S ^a   Goulet, Jennifer L ^a   Griffiths, Richard J ^c   Koller, Beverly H ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; ICOSANOID; IMMUNOGLOBULIN E; LEUKOTRIENE; MEMBRANE PROTEIN;

ALLERGY; ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ASTHMA; CATALYSIS; ENTERITIS; ENZYME ACTIVITY; GENE EXPRESSION; GENE ISOLATION; INFLAMMATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSORIASIS;

ANAPHYLAXIS; ANIMALS; ARACHIDONIC ACID; CARRIER PROTEINS; DNA, COMPLEMENTARY; EDEMA; EICOSANOIDS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN E; INFLAMMATION; MACROPHAGES, PERITONEAL; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PERITONITIS; PEROXIDASE; PLATELET ACTIVATING FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; ZYMOSAN;

EID: 0030898073     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.1065     Document Type: Article

References (55)

1. Lewis, R.A., K.F. Austen, and R.J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway, biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645-655.
2. Henderson, W.R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684-697.
3. O'Byrne, P.M. 1994. Eicosanoids and asthma. Ann. NY Acad. Sci. 744:251-261.
4. Fretland, D.J., S.W. Djuric, and T.S. Gaginella. 1990. Eicosanoids and inflammatory bowel disease: regulation and prospects for therapy. Prostaglandins Leukot. Essent. Fatty Acids. 41:215-233.
5. Fauler, J., C. Neumann, D. Tsikas, and J.C. Frolich. 1992. Enhanced synthesis of cysteinyl leukotrienes in psoriasis. J. Invest. Dermatol. 99:8-11.
6. Fauler, J., A. Thon, D. Tsikas, H. von der Hardt, and J.C. Frolich. 1994. Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis. Arthritis Rheum. 37:93-97.
7. Smith, W.L. 1992. Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol. 263:F181-F191.
8. 2. Biochim. Biophys. Acta. 117:217-231.
9. 2 enzymes: regulation and physiological role. Biochem. Pharmacol. 48:1-10.
10. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science (Wash. DC). 220:568-775.
11. 4. J. Biol. Chem. 264:19469-19472.
12. Dahlen, S.-E., J. Bjork, P. Hedqvist, K.-E. Arfors, S. Hammarstrom, J.-A. Lindgren, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA. 78:3887-3891.
13. 4: implications for the regulation of inflammatory responses. Br. J. Pharmacol. 110:423-427.
14. Lewis, R.A., and K.F. Austen. 1984. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J. Clin. Invest. 73:889-897.
15. 2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196:147-153.
16. Woods, J.W., M.J. Coffey, T.G. Brock, I.I. Singer, and M. Peters-Golden. 1995. 5-lipoxygenase is located in the euchromatin of the nucleus in the resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95:2035-2046.
17. Dixon, R.A.F., R.E. Diehl, E.E. Opas, E. Rands, P.J. Vickers, J.F. Evans, J.W. Gillard, and D.K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature (Lond.). 343:282-284.
18. Vickers, P.J., G.P. O'Neill, J.A. Mancini, S. Charleson, and M. Abramovitz. 1996. Cross-species comparison of 5-lipoxygenase-activating-protein. Mol. Pharmacol. 42:1014-1019.
19. 4 synthase. Proc. Natl. Acad. Sci. USA. 91:9745-9749.
20. Hatzelmann, A., R. Fruchtmann, K.H. Mohrs, S. Raddatz, M. Matzke, U. Pleiss, J. Keldenich, and R. Muller-Peddinghaus. 1994. Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase. Agents Actions. 43:64-68.
21. Woods, J.W., J.F. Evans, D. Ethier, S. Scott, P.J. Vickers, L. Hearn, J.A. Heibein, S. Charleson, and I.I. Singer. 1993. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935-1946.
22. Miller, D.K., J.W. Gillard, P.J. Vickers, S. Sadowski, C. Leveille, J.A. Mancini, P. Charleson, R.A.F. Dixon, A.W. Ford-Hutchinson, R. Fortin et al. 1990. Identification and isolation of a membrane protein necessary for leukotriene production. Nature (Lond.). 343:278-281.
23. 4 synthase and 5-lipoxygenase activating protein. Regulators of the biosynthesis of sulfido-leukotrienes. Ann. NY Acad. Sci. 744:78-83.
24. Reid, G.K., S. Kargman, P.J. Vickers, J.A. Mancini, C. Leveille, D. Ethier, D.K. Miller, J.W. Gillard, R.A.F. Dixon, and J.F. Evans. 1990. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J. Biol. Chem. 265:19818-19823.
25. 4 synthase pathway in mouse mast cells. J. Biol. Chem. 270:22653-22656.
26. Brock, T.G., R.W. McNish, and M. Peters-Golden. 1995. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J. Biol. Chem. 270:21652-21658.
27. El Makhour-Hojeij, Y., M.C. Baclet, H. Chable-Rabinovitch, J.L. Beneytout, and J. Cook. 1994. Expression of 5-lipoxygenase in lymphoblastoid B and T cells. Prostaglandins. 48:21-29.
28. Jakobsson, P.-J., D. Steinhilber, B. Odlander, O. Radmark, H.-E. Claesson, and B. Samuelsson. 1992. On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc. Natl. Acad. Sci. USA. 89:3521-3525.
29. 4 in human monomorphonuclear leukocytes. J. Lipid Mediators. 6:15-22.
30. Janssen-Timmen, U., P.J. Vickers, U. Wittig, W.D. Lehmann, H.J. Stark, N.E. Fusenig, T. Rosenbach, O. Radmark, B. Samuelsson, and A.J. Habenicht. 1995. Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc. Natl. Acad. Sci. USA. 92:6966-6970.
31. Janssen-Timmen, U., P.J. Vickers, U. Beilecke, W.D. Lehmann, H.J. Stark, N.E. Fusenig, T. Rosenbach, M. Goerig, O. Radmark, and B. Samuelsson. 1995. 5-lipoxygenase expression in cultured human keratinocytes. Adv. Prostaglandin Thromboxane Leukotiene Res. 23:329-331.
32. Cortese, J.F., E.W. Spannhake, W. Eisinger, J.J. Potter, and V.W. Yang. 1995. The 5-lipoxygenase pathway in cultured human intestinal epithelial cells. Prostaglandins. 49:155-166.
33. Mancini, J.A., C. Li, and P.J. Vickers. 1993. 5-lipoxygenase activity in the human pancreas. J. Lipid Mediators. 8:145-150.
34. Chen, X.-S., T.A. Naumann, U. Kurre, N.A. Jenkins, N.G. Copeland, and C.D. Funk. 1995. cDNA cloning, expression, mutagenesis, intracellular localization, and gene chromosomal assignment of mouse 5-lipoxygenase. J. Biol. Chem. 270:17993-17999.
35. Ford-Hutchinson, A.W., M. Gresser, and R.N. Young. 1994 5-lipoxygenase. Annu. Rev. Biochem. 63:383-417.
36. Dombrowitz, D., V. Flammand, K.K. Brigman, B.H. Koller, and J.-P. Kinet. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain gene. Cell. 75:969-976.
37. Hooper, M., K. Hardy, A. Handyside, S. Hunter, and M. Monk. 1987. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultures cells. Nature (Lond.). 326:292-295.
38. Humes, J.L., S. Sadowski, M. Galavage, M. Glodenberg, E. Subers, R.J. Bonney, and F.A. Kuehl, Jr. 1982. Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J. Biol. Chem. 257:1591-1594.
39. Landegren, U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J. Immunol. Methods. 67:379-388.
40. Jancso-Gabor, A., J. Szolcsanyi, and N. Jancso. 1967. A simple method for measuring the amount of azovan blue exuded into the skin in response to an inflammatory stimulus. J. Pharm. Pharmacol. 19:486-487.
41. Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
42. Goulet, J.L., J.N. Snouwaert, A.M. Latour, T.M. Coffman, and B.H. Koller. 1994. Altered inflammatory responses in leukotriene-deticient mice. Proc. Natl. Acad. Sci. USA. 91:12852-12856.
43. Rao, T.S., J.L. Currie, A.F. Shaffer, and P.C. Isakson. 1994. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 269:917-925.
44. Furue, M., and K. Tamaki. 1985. Induction and suppression of contact sensitivity to fluorescein isothiocyanate (FITC). J. Invest. Dermatol. 85:139-142.
45. Chen, X.-S., J.R. Sheller, E.N. Johnson, and C.D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature (Lond.). 372:179-182.
46. Langenbach, R., S.G. Morham, H.F. Tiano, C.D. Loftin, B.I. Ghanayem, P.C. Chulada, J.F. Mahler, C.A. Lee, E.H. Goulding, K.D. Kluckman et al. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastnc ulceration. Cell. 83:483-492.
47. + lymphocyte phenotype and immunoregulatory functions. J. Immunol. 135:1357-1360.
48. Rola-Pleszczynski, M., and I. Lemaire. 1985. Leukotrienes augment interleukin 1 production by human monocytes. J. Immunol. 135:3958-3960.
49. Myers, A., E. Ramey, and P. Ramwell. 1983. Glucocorticoid protection against PAF-acether toxicity in mice. Br. J. Pharmacol. 79:595-598.
50. Young, J.M., P.J. Maloney, S.N. Jubb, and J.S. Clark. 1985. Pharmocological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse. Prostaglandins. 30:545-551.
51. Chilton, F.C., J.T. O'Flaherty, C.E. Walsh, M.J. Thomas, R.L. Wykle, L.R. DeChatelet, and B.M. Waite. 1982. Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-SN-glycero-3-phosphocholine. J. Biol. Chem. 257:5402-5407.
52. 4 synthesis in human polymorphonuclear leukocytes. J. Clin. Invest. 70:1058-1065.
53. 4 synthase: therapeutic targets for inhibiting the leukotriene cascade. Adv. Prostaglandin Thromboxane Leukotriene Res. 22:13-21.
54. 4-induced immunoregulation. J. Immunol. 139:513-517.
55. Shornick, L.P., P. DeTogni, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R.W. Karr, T.A. Ferguson, and D.D. Chaplin. 1996. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J. Exp. Med. 183:1427-1436.